Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC

NCT00291850 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped no patient recruitment

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Paclitaxel, Cisplatin, Pegfilgrastim

Sponsor

Central European Cooperative Oncology Group